Navigation Links
Filtrona Porous Technologies to Introduce New Hydrophilic Foam Products for Advanced Wound Care at the MEDICA / COMPAMED Trade Fair
Date:11/2/2011

RICHMOND, Va., Nov. 2, 2011 /PRNewswire/ -- Filtrona Porous Technologies, a developer and manufacturer of custom fluid-handling components found in everyday products around the world, will introduce a new range of hydrophilic, polyurethane foams for Advanced Wound Care applications at the MEDICA / COMPAMED trade fair in Dusseldorf, Germany from 16 to 18 November 2011.

(Logo: http://photos.prnewswire.com/prnh/20110915/PH69155LOGO)

New innovations to be featured at the show include ultra-soft, highly absorbent Medisponge® SuperSoft foams and ultra-durable, fiber reinforced Medisponge® Composite foams.  These new products, as well as other technology samples, will be on display at the Filtrona Porous Technologies booth.

Designed with the industry's needs in mind, these new developments in hydrophilic foams expand the range of materials available for customized solutions in advanced wound care and other healthcare applications that require durability and functionality.  Filtrona Porous Technologies offers industry-wide solutions with its strong technology portfolio of hydrophilic foams, bonded fibers, and porous plastics.

Attendees are invited to visit Filtrona Porous Technologies at COMPAMED – Hall 8a, Stand C14 to view the latest technology platforms and experience first-hand how the Filtrona Porous Technologies team collaborates with customers to develop solutions for their unique fluid management challenges.

About Filtrona Porous Technologies

http://www.filtronaporoustechnologies.com/

Producing globally and delivering to 56 countries, Filtrona Porous Technologies is a developer and manufacturer of custom fluid handling components engineered from bonded fiber, polyurethane foam, and porous plastic technologies. Our components represent leading technology used in healthcare, consumer, and industrial applications that require the absorption, filtration, transfer, venting, or controlled release of liquids and vapors. Filtrona Porous Technologies is a division of Filtrona plc and is headquartered in Richmond, Virginia, USA.


'/>"/>
SOURCE Filtrona Porous Technologies
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Filtrona Porous Technologies to Display Latest Developments in Bonded Fiber and Polyurethane Foam Component Solutions at the MEDICA / COMPAMED Trade Fair
2. Filtrona Porous Technologies Realizes Innovative New Product Development Through Foam-Fiber Technology Synergy : Introducing MediSponge(R) RBR Wound Care Dressings
3. Pearl Therapeutics Highlights Its Porous Particle Cosuspension Platform, Demonstrating Universal Applicability Across Multiple Drug Classes and Combination Products
4. Zimmer Spine Introduces Industrys First Porous Metal Cervical Interbody Device
5. Micell Technologies Announces Presentation of Clinical Data at TCT 2011
6. China Medical Technologies to Announce Results for the Second Fiscal Quarter Ended September 30, 2011 on November 18, 2011
7. AquaLiv Technologies Subsidiary AquaLiv, Inc. Discusses Registration In Kenya Concerning Its HIV/AIDS Treatment
8. The Future of GPCRs in Drug Discovery: Novel technologies, leading companies, and opportunities for target expansion
9. Connectyx Technologies to Host Teleconference on Third Quarter Financial Results on Tuesday November 15, 2011
10. Life Technologies Signs Agreement with GlaxoSmithKline Biologicals S.A., Seeking Expanded Use of Platform Technologies into Companion Diagnostics
11. China Medical Technologies Recently Received Approximately 2,200,000 of its ADSs from Two Banks which Borrowed the ADSs in Connection With the Issuance of the Companys Convertible Notes in August 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/21/2017)... MELBOURNE, Australia , Feb. 21, 2017  IBM (NYSE: ... IBM Watson,s ability to detect abnormalities of the eye,s retina. ... trained a research version of Watson to recognize abnormalities in ... insights and speed in their early identification of patients who ... glaucoma, a leading cause of blindness in the developed world. ...
(Date:2/21/2017)... Medical Oxygen Concentrators Market: Overview ... Medical oxygen concentrators are used by patients ... having low level of oxygen in their blood ... are to be used only with prescription and ... concentrators work either on rechargeable lithium batteries or ...
(Date:2/21/2017)...   BeyondSpring Pharmaceuticals , a clinical stage ... immuno-oncology cancer therapies, today announced that the Company,s ... 2 trial of BeyondSpring,s innovative lead asset, ... lung cancer (NSCLC) with Docetaxel has been selected ... Immuno-Oncology Symposium in Orlando, Fla. ...
Breaking Medicine Technology:
(Date:2/21/2017)... ... February 21, 2017 , ... Individuals who have been diagnosed ... surgery, treatment, therapy and management. Regular exercise in proper environments has been shown ... their diseases. On February 23, 2017, 1:00-2:00 p.m. E.S.T., a dynamic HydroWorx ...
(Date:2/21/2017)... NJ (PRWEB) , ... February 21, 2017 , ... ... research and conference coverage in veterinary medicine, will be launching its first bi-monthly ... animal health and medicine, business and practice management, and One Health. , ...
(Date:2/21/2017)... ... 2017 , ... Atlanta-based Jvion, the leading cognitive clinical science ... practice. Predixion, which raised $42M+ to date, received $20M in its third ... Ventures, and Software AG , will bring top industry talent and an impressive ...
(Date:2/21/2017)... ... February 21, 2017 , ... A February 6 article on Healio ... It found that the treatments have led to significant improvements in weight loss and ... efforts. It also noted very few problematic results relating to the treatment. Beverly Hills ...
(Date:2/20/2017)... Ill. (PRWEB) , ... February 20, 2017 , ... ... to reduce the rate at which women are called back for additional examinations ... journal Radiology . , In 2011, the U.S. Food and Drug Administration ...
Breaking Medicine News(10 mins):